Jacobson Pharma Corporation Limited (2633)

Overview

Jacobson Pharma Corporation Limited, established in 2016 with its headquarters in Kwun Tong, Hong Kong, operates a diversified business model in the healthcare sector. Through its subsidiaries, the company has built a significant presence not just locally in Hong Kong, Macau, and Mainland China, but has also expanded its horizons to Singapore and other international markets. As a notable player in the pharmaceutical industry, Jacobson Pharma specializes in the production, marketing, and sales of a broad spectrum of healthcare products. These range from generic drugs to branded healthcare items, demonstrating the company's multifaceted approach to catering to global health needs. Furthermore, as a subsidiary of Kingshill Development Limited, Jacobson Pharma benefits from the backing and support of a larger corporate structure, enhancing its operational capabilities and market reach.

Products and Services

Jacobson Pharma Corporation Limited offers a variety of products and services across several therapeutic areas, demonstrating its commitment to enhancing health and well-being. These offerings include:

• Generic Drugs: Spanning multiple therapeutic categories such as respiratory, cardiovascular, central nervous system, gastrointestinal, and more, the company’s generic drugs offer accessible healthcare solutions for a range of conditions. Among these, specific products such as oral anti-diabetics and anti-infectives, as well as a unique arsenic trioxide oral solution, showcase Jacobson’s versatility in addressing diverse health concerns.
• Branded Medicines: Beyond generics, Jacobson Pharma markets various branded medicines, further expanding its portfolio and meeting the needs of patients seeking trusted names in healthcare.
• Health and Wellness Products: Recognizing the growing emphasis on preventive care and general wellness, the company has also ventured into health and wellness products, catering to a broader audience looking to maintain and enhance their health proactively.
• Proprietary Chinese Medicines: With roots in the rich heritage of Chinese medical traditions, Jacobson Pharma produces and sells proprietary Chinese medicines like Po Chai pills, Ho Chai Kung, and Shiling oil, catering to consumers seeking natural and traditional remedies.
• Specialized Healthcare Products: The company has diversified its product range to include specialized healthcare solutions such as Contractubex for scar treatment, Smartfish nutritional supplements, Rowatanal for hemorrhoid relief, Oncotype DX for cancer therapy decision support, and AIM Atropine, an innovative approach to managing myopia in children.

In addition to these products, Jacobson Pharma engages in the trading of medical supplies and procurement of packaging materials, offering comprehensive support to the healthcare industry. The company also emphasizes research and development, property holding, and treasury services, showcasing its multifaceted approach to business in the healthcare sector. Jacobson Pharma’s diverse product line is distributed through various channels, including hospitals, clinics, registered pharmacies, retail outlets, and directly to healthcare professionals, ensuring widespread availability of its healthcare solutions.